Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised ESKD patients with COVID-19 (n = 256 samples from 55 patients). Comparison to 51 non-infected patients revealed 221 differ...

Full description

Saved in:
Bibliographic Details
Published in:eLife
Main Authors: Gisby, Jack, Clarke, Candice L, Medjeral-Thomas, Nicholas, Malik, Talat H, Papadaki, Artemis, Mortimer, Paige M, Buang, Norzawani B, Lewis, Shanice, Pereira, Marie, Toulza, Frederic, Fagnano, Ester, Mawhin, Marie-Anne, Dutton, Emma E, Tapeng, Lunnathaya, Richard, Arianne C, Kirk, Paul DW, Behmoaras, Jacques, Sandhu, Eleanor, McAdoo, Stephen P, Prendecki, Maria F, Pickering, Matthew C, Botto, Marina, Willicombe, Michelle, Thomas, David C, Peters, James E
Format: Artigo
Language:Inglês
Published: eLife Sciences Publications, Ltd 2021
Subjects:
Immunology and Inflammation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064756/
https://ncbi.nlm.nih.gov/pubmed/33704068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.64827
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items